Home
Hester Biosciences Ltd PE Ratio

Hester Biosciences Ltd
NSE: HESTERBIO
PE
Key Highlights
- The P/E Ratio of Hester Biosciences Ltd is 50.1 as of 04 Apr 12:32 PM .
- The P/E Ratio of Hester Biosciences Ltd changed from 27 on March 2020 to 62.6 on March 2024 . This represents a CAGR of 18.32% over 5 years.
- The Latest Trading Price of Hester Biosciences Ltd is ₹ 1776 as of 04 Apr 12:23 .
- The PE Ratio of Pharmaceuticals Industry has changed from 21.0 to 40.0 in 5 years. This represents a CAGR of 13.75%.
- The PE Ratio of Automobile industry is 20.3. The PE Ratio of Finance industry is 17.8. The PE Ratio of IT - Software industry is 30.2. The PE Ratio of Pharmaceuticals industry is 40.0. The PE Ratio of Retail industry is 157.6. The PE Ratio of Textiles industry is 37.1 in 2024.
Historical P/E Ratio of Hester Biosciences Ltd
The price-to-earnings ratio (P/E ratio) is a valuation measure calculated by dividing a company's current share price by its earnings per share. P/E Ratio Formula P/E ratio = (CMP of share/ Earning per share) Types of Price to Earning Ratio 1. Forward P/E ratio: It is calculated by simply dividing the price of a single unit of a company along with the estimated earnings of a company derived from its future earning guidance. 2. Trailing P/E ratio: It is the most common metric used by investors where past earnings of a company over a period are considered.
Historical P/E Ratio of Hester Biosciences Ltd
Company Fundamentals for Hester Biosciences Ltd

Hester Biosciences Ltd
NSE: HESTERBIO
Share Price
Market Price of Hester Biosciences Ltd
1M
1Y
3Y
5Y
Last Ten Days Market Price
Date | |
---|---|
03 Apr 2025 | 1835.8 |
02 Apr 2025 | 1789.25 |
01 Apr 2025 | 1491.05 |
28 Mar 2025 | 1253.9 |
27 Mar 2025 | 1339.7 |
26 Mar 2025 | 1354.8 |
25 Mar 2025 | 1380.7 |
24 Mar 2025 | 1402.05 |
21 Mar 2025 | 1387.55 |
20 Mar 2025 | 1405.65 |
SWOT Analysis Of Hester Biosciences Ltd
BlinkX Score for Hester Biosciences Ltd
Asset Value vs Market Value of Hester Biosciences Ltd
Market Value
₹ 0
Asset Value
₹ 0
* All values are in ₹ crores
Competitive Comparison of P/E Ratio
Company | Market Cap | PE Ratio |
---|
Hester Biosciences Ltd | 1561 | 50.14 |
Sun Pharmaceutical Industries Ltd | 424706 | 36.0 |
Divis Laboratories Ltd | 152946 | 74.0 |
Cipla Ltd | 120751 | 24.2 |
Torrent Pharmaceuticals Ltd | 109983 | 59.1 |
Mankind Pharma Ltd | 100168 | 49.1 |
Company | |
---|---|
Hester Biosciences Ltd | 1561 |
Sun Pharmaceutical Industries Ltd | 424706 |
Divis Laboratories Ltd | 152946 |
Cipla Ltd | 120751 |
Torrent Pharmaceuticals Ltd | 109983 |
Mankind Pharma Ltd | 100168 |
PE Ratio of Hester Biosciences Ltd Explained
₹1561
Market cap
₹31
Earnings
50.1X
PE Ratio
The price-to-earnings ratio (P/E ratio) is a valuation measure calculated by dividing a company's current share price by its earnings per share.
P/E Ratio Formula
P/E ratio = (CMP of share/ Earning per share)
Types of Price to Earning Ratio
1. Forward P/E ratio: It is calculated by simply dividing the price of a single unit of a company along with the estimated earnings of a company derived from its future earning guidance.
2. Trailing P/E ratio: It is the most common metric used by investors where past earnings of a company over a period are considered.
PE Ratio of Pharmaceuticals Industry over time
PE Ratio of Top Sectors
Historical Market Cap of Hester Biosciences Ltd
Market Cap or market capitalisation refers to metrics that are used to measure a company's size. It is defined as the total market value of a company's outstanding shares of stock. Formula of Market Cap: Market Capital = N * P Here, N for the outstanding shares P refers to the closing price of the company's shares. Types of Companies based on Market Cap: - Small-Cap stocks: Up to 500 Crore - Mid-Cap Stocks: From Rs.500 crore up to Rs.7,000 crore - Large-Cap Stocks: From Rs.7,000 crore up to Rs.20,000 crore
Historical Market Cap of Hester Biosciences Ltd
Historical Revenue, EBITDA and Net Profit of Hester Biosciences Ltd
Revenue term means the amount of money a company earns from its primary business activities such as the sales of its products & services.\r\r\n\r\r\nTypes of Revenue:\r\r\n\r\r\n1. Operating revenue: It refers to the income generated from the core business activities, which are sales of goods or services rendered.\r\r\n\r\r\n2. Non-Operating revenue: It is the income generated from secondary sources unrelated to the primary business. Examples include rents, dividends, interest, and royalty fees.\r\r\n\r\r\nFormula for Revenue:\r\r\n\r\r\nThe formula for calculating revenue is based on two goods & services:\r\r\n\r\r\nFor goods:\r\r\nRevenue = Avg unit price x Number of Units sold\r\r\n\r\r\nFor services:\r\r\nRevenue = Avg unit price x Number of Customers served.PBIDT stands for Profit Before Interest, Depreciation, and Taxes. It is a financial metric that measures a company's profitability before accounting for interest expenses, depreciation of assets, and taxes. Formula to calculate PBIDT: PBIDT = Net Income + Interest + Depreciation + Taxes or PBIDT = Operating Income + Depreciation + Taxes PBIDT vs EBITDA vs EBIT vs EBT: Here is a brief explanation of the differences: - PBIDT (Profit Before Interest, Depreciation, and Taxes) includes taxes in its calculation, unlike EBITDA. - EBITDA (Earnings Before Interest, Taxes, Depreciation, and Amortization) excludes taxes and interest, focusing on operational performance. - EBIT (Earnings Before Interest and Taxes) excludes interest and taxes, providing a measure of core operational profitability. - EBT (Earnings Before Taxes) includes all operating income but does not account for interest expenses. Conclusion: PBIDT, similar to EBITDA, is a measure of operational profitability but includes taxes in its calculation.Net profit is the amount of money a company retains after accounting for all expenses, depreciation, interest, taxes, and other deductions.\r\r\n\r\r\nNet Profit formula is expressed as:\r\r\n\r\r\nNet Profit = Total Revenue - Total Expense\r\r\n\r\r\nNet Profit Margin Ratio:\r\r\n\r\r\nNet Profit Margin Ratio = Net Profit / Total Revenue
Historical Revenue, EBITDA and Net Profit of Hester Biosciences Ltd
Revenue
EBITDA
Net Profit
Historical Dividend Payout of Hester Biosciences Ltd
Dividend payout refers to the total dividends paid to shareholders relative to the company's earnings. It is a financial measure that determines the percentage of earnings paid out to existing shareholders as dividends. How to calculate Dividend Payout Ratio? The dividend payout ratio formula is as follows: DPR = Dividends paid / Net earnings With the dividend payout ratio, you can understand the company's priorities. It is an important metric that allows you to easily check DPR online.
Historical Dividend Payout of Hester Biosciences Ltd
About Hester Biosciences Ltd
- Hester Biosciences Limited is one of the leading and pioneering animal healthcare companies in India.
- The Company was incorporated in April, 1987 and is principally engaged in manufacturing of Poultry vaccines and Large Animal Vaccines and trading of Poultry and Large animal and Petcare health products having its manufacturing set up at Meda Adraj Village, Mehsana District, Gujarat. The Company engages in two business verticals, namely Poultry Healthcare and Animal Healthcare.
- It has built a presence in several regions of Africa and in numerous nations, including Vietnam, Indonesia, Nepal, and Bangladesh.
- The products and services offered include over 51 vaccines and 70+ health products.
- In addition, it offers a vast selection of pharmaceuticals, feed supplements, and disinfectants for poultry and large animals.
Hester Biosciences Ltd News Hub
Hester Biosciences consolidated net profit rises 8.01% in the June 2024 quarter
Net profit of Hester Biosciences rose 8.01% to Rs 6.34 crore in the quarter ended June 2024 as again
Read more
02 Aug 24
Hester Biosciences announces board meeting date
Hester Biosciences will hold a meeting of the Board of Directors of the Company on 28 October 2024.
Read more
21 Oct 24
Hester Biosciences consolidated net profit rises 100.49% in the September 2024 quarter
Net profit of Hester Biosciences rose 100.49% to Rs 8.20 crore in the quarter ended September 2024 a
Read more
28 Oct 24
Hester Biosciences receives reaffirmation in credit rating for bank facilities
Hester Biosciences has received reaffirmation in credit ratings for bank facilities at CARE BBB+; St
Read more
20 Dec 24